Grant Awards in April & October 2010

Preface >>
Facts and Figures >>

Principal Investigator Project Title/Link
1. Grant Awards in Cycle XXIII and XXIV  
1.1 Grant Awards in Cycle XXIII  
Dr Dany Anglicheau
Necker Hospital, Paris, France
Non-invasive Biomarkers of Renal Allograft Fibrosis
Dr Christian Brander
AIDS Research Institute Irsicaixa, Barcelona, Spain
A Second Shot at HCV: The Impact of HLA Mismatch for Viral Control Post-OLT
Dr Mandy L. Ford
Emory University, Atlanta, USA
Role of Memory T Cells in Transplant Rejection
Dr Thomas D. Friedrich
Albany Medical College, Albany, USA
Preventing PVAN by Inhibiting Enzymes in the Host-cell DNA-damage Response
Dr Peter M.A. Hopkins
The Prince Charles Hospital, Brisbane, Australia
Non-cultured Bacteria Hold the Key to Development and Progression of Rejection in Lung Transplant Patients
Dr Benjamin Medoff
Massachusetts General Hospital, Boston, USA
The Role of the Immune Protein TIM3 in Lung Transplantation
Dr Markus Selzner
Toronto General Hospital, Toronto, Canada
Oxygenated ex vivo Liver Perfusion as a Novel Technique for Organ Storage, Assessment, and Repair
Prof. Jean-Paul P. Soulillou
ITERT-INSERM U643, Nantes, France
The Role of B Cells in Patients Who Accept Their Kidney Graft without Any Treatment
1.2 Grant Awards in Cycle XXIV  
Dr Menna Clatworthy
Cambridge Institute for Medical Research, Cambridge, UK
Genetic Variation in FCGR2B and Renal Transplant Survival
Assoc. Prof. Maher Gandhi
Queensland Institute of Medical Research, Brisbane, Australia
Optimizing the Treatment of Lymphomas that Occur after Transplantation
Prof. Hermann-Josef Gröne
German Cancer Research Center, Heidelberg, Germany
New Treatment Option for Chronic Transplant Dysfunction
Dr Seth Karp
Beth Israel Deaconess, Boston, USA
Identifying Transplantable Organs to Expand the Donor Pool
Prof. Rajiv Khanna
Queensland Institute of Medical Research, Herston, Australia
Virus-specific Killer T cells: A Double Edged Sword in Organ Transplantation
Dr Cristina Legido-Quigley
King's College London, London, UK
Are Steroids, which Have Been Oxidised, Markers of Liver Quality for Transplant?
Dr Nazia Selzner
Toronto General Hospital, Toronto, Canada
Improving Outcomes of Hepatitis C-infected Patients after Liver Transplantation
Prof. Thomas K. Wadell
University Health Network, Toronto, Canada
Lung Progenitor Cells in Tissue Repair and Prevention of Allograft Rejection
Dr Emmanuel Zorn
Massachusetts General Hospital, Boston, USA
Analyzing the Development and Function of “Non-specific” Antibodies in the Blood of Kidney Transplant Recipients